The Consolidated Appropriations Act of 2026, signed by Trump on Feb. 3, includes a provision reinstating the Mikaela Naylon ...

Expert said, the policy encourages industry players to innovate beyond sourcing and consumption, therefore widening ...

Novartis has nixed six early-stage pipeline programs, swapping in two new phase 1 cancer candidates as replacements. | ...

Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development.

"The government has claimed that the deal will only cost around £1 billion per year, but the UK's new commitment to double ...

Danaher Corporation delivered slightly better-than-expected annual earnings, with conservative 2026 guidance that likely ...

San Diego startup tricks cancer cells with this ‘glue’ and Big Pharma bought in for billions. Now, it’s putting its science to the test in its first clinical trial.

European companies are keen to expand investment in Vietnam across a wide range of sectors, including finance, textiles, climate change mitigation, carbon and methane emissions reduction, ...

Nirmala Sitharaman’s Biopharma SHAKTI announcement in the Union Budget has worked as a booster for the biotechnology sector ...

Well, the first half of 2025 certainly threw a bit of a curveball at the pharma and biotech sectors. Despite a steady stream of new drug approvals and ongoing innovation, things didn’t quite follow ...

You can provide a way better UX than this when your app throws errors by providing your own ErrorBoundary or errorElement ...

PMGC Holdings Inc. (NASDAQ: ELAB) ("PMGC" or the "Company"), a diversified public holding company announced that it has completed the acquisition ...